Ipamorelin vs GHRP-2

What Are Ipamorelin and GHRP-2?

Ipamorelin (Ipamorelin) is a Growth Hormone Secretagogue (GHS) / Ghrelin mimetic. Synthetic pentapeptide derived from GHRP-1, engineered for selective GH release. It is researched for growth hormone release, improved sleep, fat loss, muscle recovery, bone density support.

GHRP-2 (Growth Hormone Releasing Peptide-2) is a Growth hormone secretagogue, ghrelin receptor agonist. Synthetic hexapeptide designed to stimulate GH release by mimicking ghrelin at the GHS-R receptor. It is researched for potent GH elevation, lean muscle mass gain, improved recovery, IGF-1 increases, increased appetite, bone density support.

While both are popular research peptides, they work through fundamentally different mechanisms and serve different primary purposes.

How Do Ipamorelin and GHRP-2 Work Differently?

Ipamorelin mechanism: Ipamorelin selectively stimulates GH release by mimicking ghrelin at the GHS-R receptor on pituitary somatotrophs. Unlike other GHRPs (GHRP-2, GHRP-6, Hexarelin), it does not significantly increase cortisol, prolactin, or ACTH at therapeutic doses — making it the cleanest GH secretagogue available with the fewest hormonal side effects.

GHRP-2 mechanism: Binds and activates the ghrelin receptor (GHS-R), a G-protein coupled receptor on pituitary somatotrophs. Triggers phospholipase C and inositol signaling cascades to stimulate GH secretion. Acts through both direct pituitary stimulation and indirect hypothalamic GHRH release while reducing somatostatin (GH inhibitor).

These distinct mechanisms are why the two peptides are often used for different research goals — or combined to target multiple pathways.

How Do the Dosing Protocols Compare?

Ipamorelin: 200-300 mcg administered 2-3 times daily via subcutaneous injection. Half-life: approximately 2 hours. Cycle: 8-12 weeks, often stacked with CJC-1295.

GHRP-2: 100-300 mcg per injection administered 2-3 times daily on empty stomach via subcutaneous injection, intranasal spray. Half-life: approximately 30 minutes; peak GH response ~15 minutes post-injection. Cycle: 8-16 weeks with cycling protocols recommended.

Use our peptide calculator for reconstitution math for either compound.

How Do the Benefits Compare?

Ipamorelin benefits: growth hormone release, improved sleep, fat loss, muscle recovery, bone density support.

GHRP-2 benefits: potent GH elevation, lean muscle mass gain, improved recovery, IGF-1 increases, increased appetite, bone density support.

The overlap in benefits determines whether these peptides compete for the same use case or complement each other in a stack.

How Do the Side Effects Compare?

Ipamorelin: Minimal side effects compared to other GH secretagogues. Mild headache, light-headedness, or injection site reactions possible. Does not cause the intense hunger seen with GHRP-6 or the cortisol/prolactin spikes seen with GHRP-2.

GHRP-2: Significant appetite increase within 20 minutes of injection. Elevated cortisol and prolactin in dose-dependent manner. Water retention, potential sleep quality reduction at high doses, injection site reactions. Possible insulin desensitization with chronic use.

Can You Stack Ipamorelin and GHRP-2 Together?

Many researchers combine Ipamorelin and GHRP-2 in stacking protocols. The different mechanisms mean they can potentially provide complementary effects without competing for the same receptors.

Best paired with CJC-1295 no DAC for synergistic GH release — the GHRH + GHRP combination amplifies GH pulse amplitude beyond what either achieves alone. This is the most widely recommended beginner GH peptide stack. See our stacking guide for general principles.

Which Is Better: Ipamorelin or GHRP-2?

There is no universal answer. Ipamorelin may be preferable for researchers focused on growth hormone release, while GHRP-2 is stronger for potent GH elevation.

For the most comprehensive results, many researchers combine both. Review each compound's individual guide for detailed protocols: Ipamorelin | GHRP-2.

Frequently Asked Questions